Pembrolizumab in patients with advanced soft tissue and bone sarcomas: updated efficacy results of multicenter Phase II study SARC028 and correlates of response.
Citation: Unpublished 2016/11/09/Form of publication: Poster PresentationYear: 20162017Conference information: Washington Cancer Institute: Connective Tissue Oncology Society Meeting, Lisbon, Portugal., Fiscal year: FY2017FY2017Local accession number: A2017_335Date added to catalog: 2018-08-01Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Poster Presentation | MedStar Authors Catalog | Poster | Available |